Inhibrx Biosciences Stock Forward View
| INBX Stock | USD 74.18 0.20 0.27% |
Inhibrx Stock outlook is based on your current time horizon.
At this time, the RSI of Inhibrx Biosciences' share price is approaching 46. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Inhibrx Biosciences, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (2.65) | EPS Estimate Current Year (8.12) | EPS Estimate Next Year (9.32) | Wall Street Target Price 12 | EPS Estimate Current Quarter (2.60) |
Using Inhibrx Biosciences hype-based prediction, you can estimate the value of Inhibrx Biosciences from the perspective of Inhibrx Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Inhibrx Biosciences using Inhibrx Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Inhibrx using crowd psychology based on the activity and movement of Inhibrx Biosciences' stock price.
Inhibrx Biosciences Implied Volatility | 0.99 |
Inhibrx Biosciences' implied volatility exposes the market's sentiment of Inhibrx Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inhibrx Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inhibrx Biosciences stock will not fluctuate a lot when Inhibrx Biosciences' options are near their expiration.
The Naive Prediction forecasted value of Inhibrx Biosciences on the next trading day is expected to be 73.77 with a mean absolute deviation of 1.92 and the sum of the absolute errors of 117.03. Inhibrx Biosciences after-hype prediction price | USD 72.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Inhibrx Biosciences to cross-verify your projections. Prediction based on Rule 16 of the current Inhibrx contract
Based on the Rule 16, the options market is currently suggesting that Inhibrx Biosciences will have an average daily up or down price movement of about 0.0619% per day over the life of the 2026-04-17 option contract. With Inhibrx Biosciences trading at USD 74.18, that is roughly USD 0.0459 . If you think that the market is fully incorporating Inhibrx Biosciences' daily price movement you should consider acquiring Inhibrx Biosciences options at the current volatility level of 0.99%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Inhibrx Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Inhibrx Biosciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Inhibrx Biosciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Inhibrx Biosciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Inhibrx Biosciences' open interest, investors have to compare it to Inhibrx Biosciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Inhibrx Biosciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Inhibrx. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Inhibrx Biosciences Additional Predictive Modules
Most predictive techniques to examine Inhibrx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Inhibrx using various technical indicators. When you analyze Inhibrx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Inhibrx Biosciences' financial statements to predict how it will affect future prices.
Cash | First Reported 2017-12-31 | Previous Quarter 186.6 M | Current Value 153.1 M | Quarterly Volatility 97.4 M |
Inhibrx Biosciences Naive Prediction Price Forecast For the 31st of January
Given 90 days horizon, the Naive Prediction forecasted value of Inhibrx Biosciences on the next trading day is expected to be 73.77 with a mean absolute deviation of 1.92, mean absolute percentage error of 6.97, and the sum of the absolute errors of 117.03.Please note that although there have been many attempts to predict Inhibrx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Inhibrx Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Inhibrx Biosciences Stock Forecast Pattern
| Backtest Inhibrx Biosciences | Inhibrx Biosciences Price Prediction | Buy or Sell Advice |
Inhibrx Biosciences Forecasted Value
In the context of forecasting Inhibrx Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Inhibrx Biosciences' downside and upside margins for the forecasting period are 70.25 and 77.30, respectively. We have considered Inhibrx Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Inhibrx Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Inhibrx Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.0515 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.9185 |
| MAPE | Mean absolute percentage error | 0.0238 |
| SAE | Sum of the absolute errors | 117.0266 |
Predictive Modules for Inhibrx Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inhibrx Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Inhibrx Biosciences After-Hype Price Density Analysis
As far as predicting the price of Inhibrx Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Inhibrx Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Inhibrx Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Inhibrx Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Inhibrx Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Inhibrx Biosciences' historical news coverage. Inhibrx Biosciences' after-hype downside and upside margins for the prediction period are 69.15 and 76.19, respectively. We have considered Inhibrx Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Inhibrx Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Inhibrx Biosciences is based on 3 months time horizon.
Inhibrx Biosciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Inhibrx Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inhibrx Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Inhibrx Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 3.52 | 0.11 | 0.04 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
74.18 | 72.67 | 0.15 |
|
Inhibrx Biosciences Hype Timeline
Inhibrx Biosciences is currently traded for 74.18. The entity has historical hype elasticity of 0.11, and average elasticity to hype of competition of -0.04. Inhibrx is forecasted to increase in value after the next headline, with the price projected to jump to 72.67 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.15%, whereas the daily expected return is currently at -0.13%. The volatility of related hype on Inhibrx Biosciences is about 1083.08%, with the expected price after the next announcement by competition of 74.14. The company reported the previous year's revenue of 200 K. Net Income was 1.69 B with loss before overhead, payroll, taxes, and interest of (171.77 M). Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Historical Fundamental Analysis of Inhibrx Biosciences to cross-verify your projections.Inhibrx Biosciences Related Hype Analysis
Having access to credible news sources related to Inhibrx Biosciences' direct competition is more important than ever and may enhance your ability to predict Inhibrx Biosciences' future price movements. Getting to know how Inhibrx Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Inhibrx Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NKTR | Nektar Therapeutics | (3.42) | 10 per month | 0.00 | (0.17) | 6.56 | (7.77) | 20.31 | |
| SNDX | Syndax Pharmaceuticals | (0.32) | 10 per month | 2.36 | 0.13 | 8.70 | (3.59) | 18.37 | |
| RLAY | Relay Therapeutics | 0.34 | 10 per month | 3.39 | 0.05 | 6.11 | (5.45) | 27.25 | |
| AMLX | Amylyx Pharmaceuticals | 0.08 | 9 per month | 3.11 | 0.01 | 8.11 | (5.24) | 20.49 | |
| ELVN | Enliven Therapeutics | 0.04 | 11 per month | 4.58 | 0.07 | 6.28 | (7.81) | 54.92 | |
| ORIC | Oric Pharmaceuticals | (0.07) | 9 per month | 0.00 | (0.05) | 6.63 | (4.48) | 15.34 | |
| IMTX | Immatics NV | (0.13) | 7 per month | 0.00 | (0.02) | 7.31 | (6.47) | 30.34 | |
| ATAI | ATAI Life Sciences | (0.02) | 9 per month | 0.00 | (0.16) | 5.77 | (5.54) | 22.95 | |
| SANA | Sana Biotechnology | 0.06 | 3 per month | 0.00 | (0.03) | 12.59 | (8.77) | 25.63 | |
| CVAC | CureVac NV | 0.19 | 6 per month | 0.00 | (0.11) | 3.33 | (2.80) | 18.10 |
Other Forecasting Options for Inhibrx Biosciences
For every potential investor in Inhibrx, whether a beginner or expert, Inhibrx Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inhibrx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inhibrx. Basic forecasting techniques help filter out the noise by identifying Inhibrx Biosciences' price trends.Inhibrx Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inhibrx Biosciences stock to make a market-neutral strategy. Peer analysis of Inhibrx Biosciences could also be used in its relative valuation, which is a method of valuing Inhibrx Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Inhibrx Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Inhibrx Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibrx Biosciences shares will generate the highest return on investment. By undertsting and applying Inhibrx Biosciences stock market strength indicators, traders can identify Inhibrx Biosciences entry and exit signals to maximize returns.
Inhibrx Biosciences Risk Indicators
The analysis of Inhibrx Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inhibrx Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inhibrx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.86 | |||
| Semi Deviation | 2.82 | |||
| Standard Deviation | 13.2 | |||
| Variance | 174.32 | |||
| Downside Variance | 15.43 | |||
| Semi Variance | 7.94 | |||
| Expected Short fall | (5.95) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Inhibrx Biosciences
The number of cover stories for Inhibrx Biosciences depends on current market conditions and Inhibrx Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Inhibrx Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Inhibrx Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Inhibrx Biosciences Short Properties
Inhibrx Biosciences' future price predictability will typically decrease when Inhibrx Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Inhibrx Biosciences often depends not only on the future outlook of the potential Inhibrx Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inhibrx Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.5 M | |
| Cash And Short Term Investments | 152.6 M |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx Biosciences' price analysis, check to measure Inhibrx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx Biosciences is operating at the current time. Most of Inhibrx Biosciences' value examination focuses on studying past and present price action to predict the probability of Inhibrx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx Biosciences' price. Additionally, you may evaluate how the addition of Inhibrx Biosciences to your portfolios can decrease your overall portfolio volatility.